✦ LIBER ✦

Validation of novel imaging methodologies for use as cancer clinical trial end-points

✍ Scribed by D.J. Sargent; L. Rubinstein; L. Schwartz; J.E. Dancey; C. Gatsonis; L.E. Dodd; L.K. Shankar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protein C as a surrogate end-point for c

✍ Kathleen D Liu,Michael A Matthay 📂 Article 📅 2008 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 39 KB

The validation of surrogate end points b

✍ Tomasz Burzykowski; Geert Molenberghs; Marc Buyse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Prostate-Specific Antigen (PSA) as a Sur

✍ Laurence Collette 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Definitions of Periprocedural Myocardial

✍ Baker, Nevin C.; Lipinski, Michael J.; Escarcega, Ricardo O.; Magalhaes, Marco A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 453 KB

Use of alternative methodologies for eva

✍ Sumeet Subherwal; Kevin J. Anstrom; William S. Jones; Michael G. Felker; Sanjay 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Circulating tumor cells as a potential e

✍ Samir S. Taneja 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 187 KB